FEBS Letters · 1991 · 274 citations · 17 references
Life SciencesBiochemistryMedicinal ChemistryDrug DiscoveryEnzymologyProtein BiochemistryEnzyme DiscoveryEnzyme InhibitionPeptide ChemistryPeptide Drug DiscoveryProteolytic EnzymesProteolytic ProcessingCathepsin ActivityInhibitor SpecificityPeptide Medicinal ChemistryPeptide Structure - Activity RelationshipsPeptide Structure-activity RelationshipsProline-targeted InhibitorsProtease InhibitorsProtease Selectivity
A series of new epoxysuccinyl peptides were designed and synthesized to develop a specific inhibitor of cathepsin B. Of these compounds, N-(L-3-trans-ethoxycarbonyloxirane-2-carbonyl)-L-isoleucyl-L-proli ne (compound CA-030) and N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-prol ine (compound CA-074) were the most potent and specific inhibitors of cathepsin B in vitro. The carboxyl group of proline and the ethyl ester group or the n-propylamide group in the oxirane ring were necessary, the ethyl ester group or the n-propylamide group being particularly effective for distinguishing cathepsin B from other cysteine proteinases such as cathepsins L and H, and calpains.
17
A. John Barrett, A A Kembhavi, M A Brown et al. · Biochemical Journal · 1982 · 1K citations · Full text
Action of rat liver cathepsin L on collagen and other substrates.
Heidrun Kirschke, A A Kembhavi, Peter Bohley et al. · Biochemical Journal · 1982 · 223 citations · Full text
Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo
Takae Towatari, Takeshi Nikawa, Mitsuo Murata et al. · FEBS Letters · 1991 · 217 citations